Skip to main content

Triclabendazole (International)

Note: In some countries, this medicine may only be approved for veterinary use.

In the US, Triclabendazole (triclabendazole systemic) is a member of the drug class anthelmintics and is used to treat Fascioliasis.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

P02BX04

CAS registry number (Chemical Abstracts Service)

0068786-66-3

Chemical Formula

C14-H9-Cl3-N2-O-S

Molecular Weight

360

Therapeutic Category

Anthelmintic agent

Chemical Name

1H-Benzimidazole, 5-chloro-6-(2,3-dichlorophenoxy)-2-(metyltio)-

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.